Today announced the appointment of a new board chairperson, and the naming of a new chief medical officer.
Anaconda named Richard Ferrari, the co-founder of De Novo Ventures, as chairperson. Ferrari has co-founded, led, and advised scores of medical device and biotechnology companies for more than two decades, raising some $1 billion in financing and participating in approximately $1.8 billion worth of acquisition events for emerging medical technology firms.
The company also announced the appointment of Hendrik Lambert, PhD., as chief medical officer. Lambert has more that 25 years of experience in the development of innovative medical device technologies, ranging from early-stage startups to large multi-national corporations in the cardiac, vascular, and neurological therapy spaces.